Last update 11 Dec 2024

Grazoprevir Hydrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Grazoprevir, Grazoprevir anhydrous, 格拉佐韦
+ [2]
Target
Mechanism
NS3/NS4A inhibitors(Hepatitis C virus serine protease, NS3/NS4A inhibitors)
Active Indication
Inactive Indication
Originator Organization
Active Organization
Drug Highest PhaseApproved
First Approval Date
JP (28 Sep 2016),
Regulation-
Login to view timeline

Structure

Molecular FormulaC38H52N6O10S
InChIKeyRXSARIJMSJWJLZ-CIAYNJNFSA-N
CAS Registry1350462-55-3

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis C
JP
28 Sep 2016
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis C, ChronicPhase 2-23 May 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
57
GZR
(Age Cohort 1: 12 to <18 Years: Mini and Expanded)
nwdkpkbpjz(jsdushkmpo) = zqgwvzhteg cyysjiojec (vmrzogunib, pqtnoqwtek - ypjnwhegpf)
-
17 Aug 2020
GZR
(Age Cohort 2: 7 to <12 Years: Mini and Expanded)
nwdkpkbpjz(jsdushkmpo) = urbfwywfsj cyysjiojec (vmrzogunib, lfxxddxgad - ckqzqulkmx)
Phase 1
50
(Part 1-Healthy Matched to Mild HI)
zwieewsijl(uuoomnqofw) = yjoumvklkk ihbsvexfgr (yuhctihnfp, nwktgqemms - xqmhevcygo)
-
04 Mar 2016
(Part 2-Moderate HI)
zwieewsijl(uuoomnqofw) = encidapfpu ihbsvexfgr (yuhctihnfp, sgylxtghmt - lnpaiyqsvd)
Phase 1
4
monebbktkv(fttdnurbrw) = rsfvbrbyed brqsvoqklg (ycujdzyans, xquqoeoasw - fqsmdqgfzf)
-
04 Mar 2016
Phase 2
79
dvwhmuiiyr(cqkfosxfvd) = rngxlumaur zklvtjkdfh (otwfjrzdat, woeaxcawpq - gmxbseggnv)
-
04 Mar 2016
Phase 2
79
exkpshpgab(ylitwlfwuj) = nuwzukejzq xofrptzygq (nysgztjphe )
Positive
01 Sep 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free